← Back to guidelines
Gastroenterology69 papers

Exocrine pancreatic insufficiency

Last edited: 4/14/2026

Overview

Exocrine pancreatic insufficiency (EPI) results from inadequate pancreatic enzyme secretion, leading to maldigestion and malabsorption of nutrients, often manifesting as steatorrhea, weight loss, and deficiencies in fat-soluble vitamins 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of steatorrhea, weight loss, and nutrient deficiencies 1.
  • Recommended Tests:
  • - Fecal elastase 1 (FE1) level: <200 mcg/g indicates EPI 2. - Coefficient of fat absorption (CFA) <93% confirms EPI 2. - Serum levels of fat-soluble vitamins (A, D, E, K) for assessing deficiencies 45.
  • Grading:
  • - Stage I (Mild): FE1 100-200 mcg/g; consider non-pancreatic causes if steatorrhea is present 2. - Stage II (Moderate): FE1 <100 mcg/g; assess CFA and vitamin levels 2.

    Management

  • First-Line Treatment:
  • - Pancreatic enzyme replacement therapy (PERT) to improve digestion and absorption 125.
  • Adjunctive Treatments:
  • - Supplementation with fat-soluble vitamins (A, D, E, K) to correct deficiencies 45. - Nutritional counseling to optimize dietary intake 1.

    Special Populations

  • Pediatrics: Endoscopic pancreatic function testing (ePFT) can be used for diagnosis, though its utility and interpretation require careful consideration 3.
  • Comorbidities: EPI management should consider coexisting conditions like chronic pancreatitis or malignancies, tailoring PERT and nutritional support accordingly 5.
  • Key Recommendations

  • Increase awareness and promote appropriate diagnosis and treatment of EPI to address underdiagnosis and undertreatment 1 (Evidence: Expert opinion).
  • Use fecal elastase 1 levels as a primary non-invasive test for EPI, with CFA and vitamin levels for confirmation in moderate cases 2 (Evidence: Moderate).
  • Implement pancreatic enzyme replacement therapy as first-line treatment, complemented by vitamin supplementation to manage deficiencies 145 (Evidence: Moderate).
  • References

    1 Whitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology 2023. link 2 Khan A, Vege SS, Dudeja V, Chari ST. Staging exocrine pancreatic dysfunction. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2022. link 3 Patel N, Sellers ZM, Grover A, Liu QY, Maqbool A, Morinville VD et al.. Endoscopic Pancreatic Function Testing (ePFT) in Children: A Position Paper From the NASPGHAN Pancreas Committee. Journal of pediatric gastroenterology and nutrition 2021. link 4 Barko PC, Williams DA. Serum concentrations of lipid-soluble vitamins in dogs with exocrine pancreatic insufficiency treated with pancreatic enzymes. Journal of veterinary internal medicine 2018. link 5 Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G et al.. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World journal of gastroenterology 2013. link

    Original source

    1. [1]
    2. [2]
      Staging exocrine pancreatic dysfunction.Khan A, Vege SS, Dudeja V, Chari ST Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (2022)
    3. [3]
      Endoscopic Pancreatic Function Testing (ePFT) in Children: A Position Paper From the NASPGHAN Pancreas Committee.Patel N, Sellers ZM, Grover A, Liu QY, Maqbool A, Morinville VD et al. Journal of pediatric gastroenterology and nutrition (2021)
    4. [4]
    5. [5]
      Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas.Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G et al. World journal of gastroenterology (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG